FdaApplication

ANDA 211943

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSAPTALIS PHARMACEUTICALS LLC
application_typeANDA
approval_date2024-07-05

Products (1)

ProductActive ingredientStrengthDosage form
CYCLOSPORINECYCLOSPORINE0.05%EMULSION;OPHTHALMIC

1 product